Heather B. Deixler

San Francisco
  • 505 Montgomery Street
  • Suite 2000
  • San Francisco, CA 94111-6538
  • USA
 
 

Heather Deixler counsels public and private companies operating in the healthcare industry on transactional and regulatory matters.

Ms. Deixler advises hospitals, physician organizations, health plans, insurers, as well as digital health, pharmaceutical, and medical device companies on:

  • Privacy
  • Physician self-referral (i.e. the federal Stark law and its state counterparts) 
  • Fraud and abuse

Ms. Deixler is a Certified Information Privacy Professional (CIPP/US and CIPP/E) with a particular focus on health information privacy and security, including compliance with the Health Insurance Portability and Accountability Act of 1996 (HIPAA), the Health Information Technology for Economic and Clinical Health Act of 2009 (HITECH), and federal and state privacy and information security laws.

She works with clients to develop and implement compliance programs and respond to security breaches, advise on regulatory compliance matters related to healthcare privacy and security including online privacy policies and terms of services, and counsels on such issues in healthcare transactions.  

Ms. Deixler also counsels companies outside of the healthcare industry on general privacy and security matters, including online privacy and mobile app issues. 

Ms. Deixler previously served as an Adjunct Professor in the Health Law LLM program at the University of Washington School of Law. Prior to attending law school she worked as a research technician in a neurophysiology laboratory in Dijon, France, and as a clinical research assistant at the Beth Israel Deaconess Medical Center in Boston.

Ms. Deixler’s representative experience includes advising:

Mergers and Acquisitions
  • Preventice Solutions, Inc. in its US$1.23 billion sale to Boston Scientific
  • Cerner Corporation in connection with its pending acquisition of Kantar Health for US$375 million
  • Adventist Health in connection with its acquisition of Blue Zones LLC, a facilitator of healthy living
  • 10x Genomics in the acquisitions of ReadCoor, Inc., a developer of foundational In Situ technologies, and also CartaNA AB, developers of In Situ RNA analysis technology
  • Varian Medical Systems in its acquisition of Cancer Treatment Services International, an owner and operator of a network of cancer treatment facilities 
  • PharMerica, a subsidiary of KKR, in its acquisition of BrightSpring Health Services, a provider of diversified home and community-based health services to complex populations
  • HMS in connection with its US$3.4 billion sale to Veritas-backed Gainwell Technologies
  • Ginkgo Bioworks in its US$15 billion de-SPAC merger  with Soaring Eagle Acquisition Corp.
  • eFFECTOR Therapeutics on its de-SPAC merger with Locust Walk Acquisition Corp.
  • Owlet Baby Care Inc. in its proposed US$1.39 billion de-SPAC merger with Sandbridge Acquisition Corporation
  • GRAIL in connection with its pending acquisition by Illumina for US$8 billion and contingent value rights
Capital Markets
  • GoodRx Holdings Inc. in its initial public offering (IPO)
  • Treace Medical Concepts, Inc. in its IPO
Thought Leadership

Ms. Deixler writes and speaks frequently on a variety of healthcare and data privacy topics, including the use of AI/ML in healthcare and the recently finalized Information Blocking and Interoperability Rules.

A selection of her thought leadership includes:

Presentations
  • “Information Blocking Is Here: A Deep Dive into the Practical Application of the ONC Rule after One Year, FAQs, and Unanswered Questions,” co-panelist for AHLA Webinar (May 6, 2021)
  • “Interoperability and Information Blocking: CMS and ONC Rules Implementing the 21st Century Cures Act,” co-panelist for AHLA Webinar (November 17, 2020)
  • “Contagion: Battling COVID-19 and Future Pandemics with AI and Robotics,” moderator for panel at ABA AI and Robotics National Institute (October 7, 2020)
  • “Whose Data is it Anyway? Privacy, Patient Engagement, HIPAA and Beyond," co-presenter with Shannon B. Hartsfield, ABA Virtual Emerging Issues in Healthcare Law Conference (April 17, 2020) 
  • “COVID-19: Considerations for Healthcare Facilities Responding to the Pandemic,” co-panelist for ABA Webinar (March 30, 2020)
Publications
  • “Will You Share My Data, Please?,” co-authored with Ty Kayam, The SciTech Lawyer, Vol. 17, No. 4, Summer 2021. 
  • “Chatbots Meet COVID-19, Why Lawyers Should Pay Attention,” co-authored with Karen Silverman, The SciTech Lawyer, Vol. 17. No 1, Fall 2020, AI and Healthcare (September 25, 2020)
  • “HHS’ Sweeping Interoperability and Information Blocking Final Rules Bring Patient Health Data Access into the 21st Century,” AHLA Weekly Alert (March 13, 2020)
 
 
 
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.